India to Iraq: Cefixime Export Trade Route

The India to Iraq Cefixime corridor is one of India's established pharmaceutical export routes, with 125 shipments documented worth a combined $6.7M USD. The route is dominated by MICRO LABS LIMITED, which alone accounts for roughly 44% of all export value, reflecting the consolidated nature of India's cefixime manufacturing sector.

Across 24 active suppliers, the average shipment value stands at $53.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with cefixime's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 33.1%, placing it at rank #20 among India's top cefixime export destinations globally.

On the import side, key buyers of Indian cefixime in Iraq include AL-KAWKAB SCIENTIFIC BUREAU, KAWKAB SCIENTIFIC BUREAU, HAWKARY PHARMACEUITCAL CO. and 27 others. AL-KAWKAB SCIENTIFIC BUREAU is the single largest importer with 31 shipments valued at $2.3M USD.

India's cefixime exports to Iraq are driven primarily by a handful of large-scale manufacturers. MICRO LABS LIMITED with 34 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 24 active exporters signals a competitive but concentrated market — buyers in Iraq benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MICRO LABS LIMITED, AJANTA PHARMA LIMITED, AJANTA PHARMA LIMITED — together account for 85% of total trade value on this route. The average shipment value of $53.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as supixime-100 dry syrup (cefixime for ora and supixime 400 (cefixime 400mg capsules) (1x6s) - tax invoice no: 707202202 dt: 31.05.2024, suggesting that buyers in Iraq tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AL-KAWKAB SCIENTIFIC BUREAU is the largest importer with 31 shipments worth $2.3M USD — representing 35% of all cefixime imports from India on this route. A total of 30 buyers are active on this corridor.